Ensemble, trouvons des traitements
Fondation Maladies Rares (fondation-maladiesrares.org) scores 80 out of 100 on Brand Analyzer, placing it in the Brand-Ready tier among Healthcare brands, Non-profit brands, Education brands, in the 75th percentile of 18385 Healthcare brands.
Fondation Maladies Rares is a French nonprofit organization based in Paris, founded in 2012. It supports and coordinates scientific research on rare diseases, facilitating knowledge sharing among researchers, clinicians, healthcare professionals, patient associations, and institutions. The foundation aims to accelerate scientific progress and treatment development by uniting research and care stakeholders working on rare diseases.
| Brand Name | Fondation Maladies Rares |
|---|---|
| Domain | fondation-maladiesrares.org |
| Industry | Healthcare, Non-profit |
| Founded | 2012 |
| Headquarters | Paris |
| Main Competitors | EURORDIS (80/100), National Organization for Rare Disorders (NORD) (86/100), Orphanet (76/100), AFM-Téléthon (79/100), Institut Imagine |
Moz Domain Authority 40/100 vs category average 40 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #2,103,415 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "La Fondation Maladies Rares favorise la conduite de projets de recherche scientifique ainsi que le partage de connaissances sur les maladies rares." (Meta description: 22 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: 1 JSON-LD block(s), Organization schema, Breadcrumb/Website schema, og:title, og:description, og:image, og:type, Twitter cards, canonical. Adding FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Content is FR-only, limiting citation in English-language AI answers.
Detected tech stack: WordPress, Ghost.
Social footprint: verified profiles on LinkedIn, X (Twitter), YouTube, Facebook, Instagram; no detected presence on GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Live results from asking a general-purpose AI assistant about the brand, checked October 2026.
When asked "What is Fondation Maladies Rares?", Claude could identify the brand as of October 2026. Fondation Maladies Rares is a French foundation created to coordinate and fund research on rare diseases, bringing together patients, clinicians, and researchers across France. It supports diagnosis, research projects, and networking among the many actors involved in rare disease Best known for Coordinating and funding rare disease research and networks in France.
When asked "Best brands similar to Fondation Maladies Rares?", Claude would recommend Fondation Maladies Rares as of October 2026. It's a well-established and respected reference point in France for rare disease research funding and coordination, so it would come up naturally in that context.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Fondation Maladies Rares's main competitors in Healthcare: EURORDIS (80/100), National Organization for Rare Disorders (NORD) (86/100), Orphanet (76/100), AFM-Téléthon (79/100).
Sources: Brand Analyzer scan
Fondation Maladies Rares is a French nonprofit foundation based in Paris, established in 2012, dedicated to advancing scientific research and knowledge sharing in the field of rare diseases. It operates within the healthcare, non-profit, and education sectors, bringing together researchers, clinicians, and patient associations to support collective progress against rare diseases.
Fondation Maladies Rares has limited AI-search visibility, scoring 35/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 46, recommendation 48). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Fondation Maladies Rares was founded in 2012. Fondation Maladies Rares operates in the Healthcare category. It is analyzed by Brand Analyzer across seven brand dimensions and AI-search visibility.
Sources: Wikidata
Fondation Maladies Rares is headquartered in Paris. Fondation Maladies Rares operates in the Healthcare category.
Sources: Wikidata
Fondation Maladies Rares offers support for scientific research projects on rare diseases and facilitates the sharing and dissemination of knowledge in this field. It serves as a coordinating body connecting researchers, clinicians, and patient associations to collectively advance rare disease research.
Fondation Maladies Rares scores 48/100 on Brand Analyzer's AI recommendation signal, indicating it is less likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Fondation Maladies Rares can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Fondation Maladies Rares is used by researchers, healthcare professionals, patient associations, and institutions involved in the research and treatment of rare diseases.
Fondation Maladies Rares is known for coordinating and accelerating scientific research on rare diseases in France by federating researchers, clinicians, and patient associations to promote collective scientific advancement.
Fondation Maladies Rares scores 35/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Fondation Maladies Rares has a weak AI-visibility profile at 35/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (48/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #2,103,415 (Tranco) and a Moz Domain Authority of 40/100. The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data and no llms.txt to steer AI to its best pages. In a live check, Claude could already identify Fondation Maladies Rares from memory (October 2026) - a sign these signals are paying off.
The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark.
Ranked closest to Fondation Maladies Rares: Fondation Alzheimer (80/100), FOLX Health (80/100), International Food Information Council (IFIC) (80/100), Force Therapeutics (80/100).
A step up - brands to learn from: Zymo Research (81/100), Zurich Insurance Group (81/100).
Category leader: Booksy (96/100).
Brand Analyzer is built by DataEase AI. Track your brand in ChatGPT, Gemini and Perplexity.